All Articles

Browse the full archive, newest first.

Briefing: Who do you think you are? What DNA tests reveal—and what they don't

Strategic angle: Exploring the impact of DNA testing on personal identity and criminal investigations.

Briefing: Commanders confident in LB core if Wagner gone

Strategic angle: The Commanders noted the value of veteran free agent LB Bobby Wagner's leadership but said they are confident in the players they've added at his position.

Editorial Staff Mar 29

Travel

Briefing: If You’ve Been Squinting Through Oncoming Traffic At Night, You’re Not Imagining It

Strategic angle: AAA survey shows most drivers struggle with headlight glare, with many saying the problem has worsened in recent years.

Editorial Staff Mar 29

Sports

Briefing: Former Vikings All-Pro safety Browner dies at 65

Strategic angle: Joey Browner, the first defensive back selected by the Vikings in the first round and a member of the team's Ring of Honor, died Saturday at the age of 65.

Editorial Staff Mar 29

Sports

Briefing: Gamecocks land OL recruit with no football chops

Strategic angle: Neff Giwa, a 20-year-old Irishman who has never played American football, has committed to play at South Carolina as an offensive lineman.

Editorial Staff Mar 29

Tech

Briefing: Typing and Keyboards

Strategic angle: Exploring the evolution and impact of typing technology.

Editorial Staff Mar 29

Tech

Briefing: Show HN: I made a "programming language" looking for feedback

Strategic angle: A new programming language seeking community input and suggestions.

Editorial Staff Mar 29

Energy

Briefing: Five things to know about rare earth elements

Strategic angle: Understanding the significance of rare earth elements in today's economy.

Editorial Staff Mar 29

Politics

Briefing: Hundreds evacuated as fire rips through German nightclub

Strategic angle: Roughly 750 people were successfully evacuated as a fire ripped through a nightclub in southwest Germany.

Editorial Staff Mar 29

Money

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market

U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.

Editorial Staff Mar 29